Close

Oncosec Medical (ONCS) Announces Positive Interim Data from ImmunoPulse IL-12 + KEYTRUDA Trial in Metastatic Melanoma

Go back to Oncosec Medical (ONCS) Announces Positive Interim Data from ImmunoPulse IL-12 + KEYTRUDA Trial in Metastatic Melanoma